Signalling by the cytokine LIF and its downstream transcription factor, STAT3, prevents differentiation of pluripotent embryonic stem cells (ESCs). This contrasts with most cell types where STAT3 signalling induces differentiation. We find that STAT3 binding across the pluripotent genome is dependent on Brg1, the ATPase subunit of a specialized chromatin remodelling complex (esBAF) found in ESCs. Brg1 is required to establish chromatin accessibility at STAT3 binding targets, preparing these sites to respond to LIF signalling. Brg1 deletion leads to rapid polycomb (PcG) binding and H3K27me3-mediated silencing of many Brg1-activated targets genome wide, including the target genes of the LIF signalling pathway. Hence, one crucial role of Brg1 in ESCs involves its ability to potentiate LIF signalling by opposing PcG. Contrary to expectations, Brg1 also facilitates PcG function at classical PcG targets, including all four Hox loci, reinforcing their repression in ESCs. Therefore, esBAF does not simply antagonize PcG. Rather, the two chromatin regulators act both antagonistically and synergistically with the common goal of supporting pluripotency.
esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function activator of transcription 3), are essential for pluripotency, and withdrawal of LIF leads to differentiation of mESCs. Recent studies have shown 'naive' human ESCs and reprogramming of human fibroblasts into naive hESCs are also LIF dependent [15] [16] [17] . STAT3 functions downstream of LIF and other cytokines in many cell types to induce differentiation, but STAT3 signalling in ESCs opposes differentiation signals provided by the ERK (extracellular signal-regulated kinase)/MAPK (mitogen-activated protein kinase) pathways 18 . The observed genome-wide co-localization of Brg1 and STAT3 (ref. 11) indicates that the LIF signalling pathway is integrated with ATP-dependent remodelling, and raises the intriguing possibility that the specialized outcome of STAT3 signalling in ESCs (that is, pluripotency) is dependent on esBAF.
PcG and trithorax complexes play classical antagonistic roles in development. The SWI/SNF ATPase in Drosophila, Brm, is known to antagonize the function of PcG during fly development and is hence classified as a trithorax protein. PcG proteins play essential roles in stem cells by repressing differentiation genes 19 and by regulating genes involved in metabolism and cell proliferation 20 . Consistent with the studies of PcG (also known as Pc) and Brm in Drosophila, we observed that esBAF avoids co-binding with PcG components genome wide in mESCs (ref. 11) , indicating that they have antagonistic functions
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Direct and functional targets BR1 in ESCs. However, whether the critical functions of PcG and BAF in ESCs involve their mutual antagonism is unknown. The mechanism underlying the antagonism between PcG and mSWI/SNF or BAF has also been controversial [21] [22] [23] . Here, we present evidence that esBAF prepares the ESC genome to receive LIF/STAT3 signals by opposing PcG repression of these targets. In contrast to expectations, Brg1 acts both synergistically and antagonistically with PcG, with the common goal of sustaining a transcription network that is compatible with pluripotency.
RESULTS

Coordinate regulation of esBAF and LIF target genes
Binding sites for Brg1 and the transcription factor STAT3 overlap extensively throughout the ESC genome 11 . The observed/expected overlap for Brg1 and STAT3 is substantially higher than for Brg1 and RNA polymerase II (PolII; Supplementary Fig. S1a ), indicating functional dedication of Brg1 and STAT3. Hence, we investigated whether they transcriptionally regulate a similar set of genes in ESCs. To completely remove the Brg1 protein, we prepared an ESC line from Brg 1 lox/lox ;actin-CreER mice, which we refer to as Brg1 cond , in which the gene encoding the ATPase Brg1 is acutely deleted by homologous recombination following 4-hydroxytamoxifen (4-OHT) treatment. Depletion of Brg1 leads to near complete loss of Oct4 (also known as Pou5f1, POU domain, class 5, transcription factor 1), Sox2 (SRY-box containing gene 2 protein) and Nanog expression and pluripotency after about 10 days 11 . However, by studying acutely deleted ESCs before the pluripotency transcriptional circuit is shut down (Fig. 1a) , we defined a set of Brg1-dependent genes by comparing wild-type Brg1 cond with 4-OHT-treated Brg1 cond ESCs. We also defined a set of LIF-dependent genes in the Brg1 cond ESC line by carrying out microarray analysis of cells starved of LIF for 48 h compared with cells grown with LIF. Surprisingly, Brg1 and LIF co-repress and co-activate a large number of common genes (Supplementary Fig. S1b , P value 5 × 10 −212 , hypergeometric distribution and Fig. 1b) , showing that Brg1-deleted or LIF-starved ESCs undergo very similar changes in the global transcriptional profile, indicating that Brg1 may be required for LIF-dependent STAT3-mediated gene regulation. Most direct co-target genes (that is, genes co-bound by Brg1 and STAT3, see Methods) were in fact co-activated by the two proteins ( Fig. 1c ; genes in the bottom-right corner, BR1, see Methods and Supplementary Table S1 ). Furthermore, this co-activated group includes a number of genes essential for pluripotency, including Esrrb, Tcl1, Tbx3 and c-KIT (also known as Kit ). Our previous studies using short hairpin RNA (shRNA)-mediated depletion of Brg1 showed that esBAF predominantly represses transcription and tonically suppresses ESC-specific genes to maintain the pluripotent transcriptional circuitry 11 . Our present studies confirm the role of esBAF as a repressor ( Supplementary Fig. S1c ), but genetic depletion of Brg1 revealed that esBAF represses and activates about equal numbers of genes ( Supplementary Fig. S1c ).
As Brg1 and BAF are generally thought to function at active promoters, the ability of Brg1 to co-activate genes with STAT3 may be nonspecific. However, we did not observe the same transcriptional co-regulation between Brg1 and Oct4 (refs 24,25) or Sox2 (ref. 21) . Rather, Brg1 functions with Oct4 and Sox2 to both repress and activate a large number of common and direct targets, but also in opposition to Oct4 and Sox2 at a different subset of targets ( Supplementary Fig. S1d ). The highly overlapping gene expression pattern between Brg1-knockout and LIF-starved cells is also not due to impaired LIF/STAT3 signal transduction in Brg1-knockout ESCs, because Brg1-knockout ESCs express normal levels of the LIF chimaeric receptor consisting of gp130 (glycoprotein 130) and the LIF receptor ( Fig. 1d and Supplementary Fig. S1e ). Brg1-knockout ESCs have normal levels of both total and phosphorylated (that is, activated) STAT3 ( Fig. 1d and Supplementary Fig. S1e ), normal kinetics of STAT3 phosphorylation following LIF stimulation (Fig. 1e ) and normal nuclear localization of phosphorylated STAT3 ( Supplementary Fig. S1f ). Last, Brg1-knockout ESCs are not merely undergoing spontaneous differentiation, because we did not observe a positive correlation of gene expression between Brg1-knockout ESCs and differentiated embryoid bodies ( Supplementary Fig. S1g ).
esBAF participates in STAT3-mediated activation of genes on target chromatin
To further investigate the mechanism of STAT3 and Brg1 co-activation, we examined the genes most markedly and directly regulated by Brg1 and LIF (that is, BR1 genes). Whereas most BR1 genes showed LIF-responsive reactivation in wild-type ESCs following LIF starvation, this response is generally lost in Brg1-knockout ESCs ( Supplementary  Fig. S2a ). Hence, STAT3-dependent gene activation is impaired in the absence of functional esBAF complexes.
We expanded these findings genome wide by carrying out microarray analyses of LIF-starved wild-type and knockout ESCs, followed by a 30 min LIF restimulation ( Supplementary Fig. S2b ). Indeed, a large number of genes showed defective upregulation in response to LIF in Brg1-knockout ESCs. More strikingly, many genes that are not LIF responsive in wild-type ESCs are instead activated in response to LIF in Brg1-knockout ESCs (blue square, 'ectopic STAT3 activation'), indicating that Brg1 is essential for ensuring that the correct complement of STAT3 targets involved with pluripotency are activated in ESCs in response to LIF.
esBAF is crucial for genome-wide STAT3 binding to target chromatin
The loss of LIF responsiveness at genes co-activated by STAT3 and Brg1 prompted us to examine the ability of STAT3 to bind its target sites on chromatin in the absence of Brg1. Chromatin immunoprecipitation (ChIP) showed that STAT3 binding is impaired at many of the co-activated gene targets from the BR1 group in Brg1-knockout ESCs when compared with wild-type ESCs (Fig. 2a) (Fig. 2b) , with an emergence of 103 new sites in Brg1-knockout ESCs ( Supplementary Fig. S3a ). Hence, Brg1 is required to shape STAT3 responsiveness in ESCs by enabling it to bind to its appropriate targets. Even among the 442 sites judged to be Brg1 independent, we found reduced STAT3 binding after Brg1 deletion (Fig. 2b) , indicating that Brg1 independence is a quantitative and not a qualitative difference.
Consistent with early studies of SWI/SNF recruitment, the levels of esBAF components, Brg1, BAF155 and BAF57, are decreased at STAT3/Brg1 co-binding sites on LIF withdrawal, albeit only moderately ( Supplementary Fig. S3b ). Hence, we do not rule out the possibility that STAT3 plays a minor role in recruiting esBAF. This genome-wide analysis revises the commonly accepted view that SWI/SNF-like complexes are solely recruited by transcription factors. Rather, we favour an interdependent model of recruitment, where STAT3 and Brg1 binding are mutually reinforced. However, the binding of STAT3 is strictly dependent on Brg1.
Enhancement of LIF/STAT3 provides partial rescue to
Brg1-knockout ESCs
Brg1 regulates a large number of genes that are unrelated to LIF signalling and indeed Brg1 co-binds many target genes with Oct4, Sox2, Nanog and Smad1 (SMAD family member 1; ref. 11). Hence, to determine whether the observed contribution of Brg1 to STAT3 recruitment is functional, we examined the ability of increased STAT3 activity to rescue the self-renewal defects observed in Brg1-knockout ESCs. We constructed a Brg1 cond ESC line expressing green fluorescent protein (GFP) and STAT3ER, which is inducibly localized to the nucleus in the presence of 4-OHT (ref. 26 ; Fig. 2c ) and is sufficient to maintain wild-type ESCs in an undifferentiated state in the absence of LIF ( Supplementary Fig. S3c ). In Brg1 cond STAT3ER ESCs, the addition of 4-OHT simultaneously induces Brg1 deletion and STAT3ER nuclear localization. When we put these GFP + Brg1-knockout STAT3ER ESCs and Brg1-knockout GFP − empty vector control ESCs in competitive growth with wild-type GFP − ESCs in the presence of 4-OHT, we noticed a small but significant and reproducible increase in the proportion of Brg1-knockout ESCs expressing STAT3ER when compared with the empty vector control (Fig. 2c) , indicating that STAT3ER expression partially alleviates the self-renewal defect in Brg1-knockout ESCs. In addition, the transcription levels of many Brg1-dependent STAT3-activated targets and phospho-STAT3 binding were rescued by the enforced nuclear localization of STAT3ER (Fig. 2d,e) . These results confirm that one of the functions of Brg1 in ESCs is to facilitate STAT3-mediated transcription. However, the incomplete rescue by STAT3 implies that Brg1 is also involved in other pathways required for ESC maintenance in addition to LIF/STAT3 signalling, as evidenced by its extensive co-binding with other regulators of pluripotency, such as Oct4 and Sox2. when compared with Brg1-independent sites (Fig. 3a) . The tag density of a protein reflects the average protein occupancy of a site, and a lower tag density can indicate lower binding affinity to the chromatinized DNA-binding site 27 . This observation indicates that lower affinity or less stable STAT3 sites are more dependent on Brg1 for STAT3 binding, indicating that there are underlying differences between high-affinity and low-affinity sites. Previous studies in yeast found that SWI/SNF dependency of a transcription factor at a particular site inversely correlates with how closely the site matches the consensus-binding motif 28 . The STAT3 consensus motif derived from our data set, TTCCNGGAA (Fig. 3b) , matches the published consensus motif 29 . A total of 65% of Brg1-dependent STAT3-binding sites contain the consensus motif, as do 66% of the Brg1-independent sites. Hence, the observed difference in affinity is not simply due to differences in the underlying sequence of the STAT3-binding site.
Brg1
More than 80% of Brg1-binding regions coincide with a DNaseI hypersensitive site 30 in mESCs ( Supplementary Fig. S4a ), indicating that Brg1-dependent STAT3 sites have lower affinity owing to lower intrinsic chromatin accessibility. Hence, we examined the accessibility of Brg1-dependent versus Brg1-independent STAT3 sites using a DNaseI hypersensitivity assay coupled to quantitative PCR (qPCR) amplification of the target region to quantitatively assess the 'openness' of a region 31 . Indeed, Brg1-dependent STAT3 sites are less accessible when compared with Brg1-independent STAT3 sites, as shown by their greater resistance to digestion by DNaseI (Fig. 3c) . Brg1 deletion decreases accessibility more at Brg1-dependent STAT3 sites than at Brg1-independent STAT3 sites ( Fig. 3d and Supplementary Fig. S4b ). The observed decreased accessibility is a direct consequence of the loss of Brg1 and not loss of STAT3 and transcription of the nearest target gene, because these sites do not lose accessibility in wild-type ESCs 
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Log 2 (knockout/wild-type tag density) starved of LIF ( Supplementary Fig. S4c, top) , which results in a loss of STAT3 binding and attenuation of transcription ( Supplementary  Fig. S4c, bottom) . Hence, Brg1 prepares most STAT3 sites for phospho-STAT3 dimers entering the nucleus in response to LIF by making these sites accessible.
Brg1 regulates levels of H3K27me3 at its target genes
The observation that esBAF is required to mediate accessibility of chromatin for STAT3 binding prompted us to examine histone modifications in Brg1-knockout ESCs. Brg1 deletion did not result in a significant change in the activating marks, H3K4me3 or H4 acetylation at the promoters of Brg1-dependent STAT3-activated targets ( Supplementary Fig. S5a ). However, we observed a general increase of the repressive modification H3K27me3 at STAT3 sites ( H3K27me3 is deposited by polycomb repressive complex 2 (PRC2). Hence, these results are consistent with our earlier studies where we found that Brg1 and the PRC2 component, Suz12 (suppressor of zeste 12 homologue), avoided co-binding over the genome of ESCs 11 . We were initially skeptical of the lack of co-localization between Brg1 and Suz12/PRC2, because Brg1 extensively co-localizes with Oct4/Sox2, and Suz12/PRC2 also co-localizes with Oct4/Sox2 in human ESCs (ref. 32) . However, when we compared the target gene overlap of Suz12/PRC2 (refs 29,33) , Oct4/Sox2 (ref. 29) and Brg1 in mESCs, we found that although Suz12/PRC2 does co-occupy some Oct4/Sox2 targets, the overlap is far less than that between Oct4/Sox2 and Brg1 ( Supplementary Fig. S5c ), providing an explanation for the apparent discrepancy between reports. As the functional interaction between These genes were grouped according to the fold change in Brg1-knockout ESCs (DR3 represents threefold downregulated, UR3 represents threefold upregulated and so on). The number within parentheses beside each set identifier (top panel) denotes the number of genes within that set. The bottom panel illustrates the average input tag density of UR3 (for a) or DR3 (for b) genes and is representative of other subsets.
BAF and PcG is an outstanding question, we expanded our findings to a genome-wide scale by ChIP-seq mapping of the histone mark H3K27me3 in wild-type and Brg1-knockout ESCs. Examination of functional Brg1-binding regions (that is, Brg1 sites that can be assigned to a nearby target gene whose expression is Brg1-dependent, see Methods) revealed significant changes in the levels of H3K27me3 at Brg1-binding regions and also at the transcription start sites (TSS) of corresponding Brg1-regulated genes (Fig. 4) . These changes occur directly over genomic regions with the highest levels of Brg1 binding ( Supplementary Fig. S5d ), indicating that Brg1 directly influences local levels of H3K27me3. Surprisingly, Brg1 deletion does not lead solely to an increase in H3K27me3 at Brg1 target genes, as would be expected if Brg1 and PRC2 solely antagonized each other. Rather, we observed both a significant decrease in H3K27me3 at Brg1-repressed genes ( Fig. 4a) , and an even more significant increase in H3K27me3 at Brg1-activated genes (Fig. 4b) . In both cases, the extent of the change in H3K27me3 is directly proportional to the degree of change in expression of Brg1-activated genes on Brg1 deletion. Unlike in Snf5 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily b, member 1)-deficient tumours 23 , acute deletion of Brg1 does not lead to upregulation of the PRC2 components Ezh2 (enhancer of zeste homologue 2) or Suz12 ( Supplementary Fig. S5e ). Consistent with this finding, bulk levels of H3K27me3 are not increased in Brg1-knockout ESCs (Supplementary Fig. S5f) . By comparing the total number of normalized ChIP-seq tags recovered from wild-type and knockout ESCs in contiguous 0.5 Mb windows, we confirmed that there is no overall genome-wide increase in H3K27me3 levels in Brg1-knockout ESCs (Supplementary Fig. S5g ). Hence, PRC2 activity does not generally increase in Brg1-knockout ESCs, in contrast to the general increase in PRC2 expression and activity in tumours deficient in Snf5 (also known as Smarcb1), revealing inherent differences in BAF and PcG antagonism in non-transformed versus transformed cell types.
Brg1 acts synergistically with PcG at all four Hox loci
Brg1 is generally considered a trithorax gene and would be expected to antagonize PcG repression of Hox genes. Although there is no global decrease in H3K27me3 in Brg1-knockout ESCs, we found a marked decrease in total normalized tag numbers derived from genomic regions containing the Hox clusters in Brg1-knockout ESCs when compared with wild-type ESCs (Fig. 5a,b) . This was confirmed by ChIP assays (Fig. 5c ) at representative Hox genes, indicating that Brg1 aids in the silencing of PcG-repressed genes in ESCs to prevent premature differentiation. Consistent with this finding, deletion of Brg1 results in the transcriptional derepression of these representative Hox genes ( Supplementary Fig. S5h ).
Brg1 antagonizes PcG at STAT3 and other targets
To examine the genes where Brg1 and PRC2 seem to act antagonistically, we expanded the above analysis of STAT3 target genes in Fig. 3e to include all genes in BR1. Indeed, at the TSS (Fig. 6a , top left graph) and STAT3 site (Fig. 6a , top right graph) of such genes, we found a significant overall increase in the H3K27me3 levels in Brg1-knockout ESCs when compared with wild-type ESCs. Once again, the changes in H3K27me3 occur over genomic regions containing high levels of Brg1 binding, indicating a direct effect of Brg1 on H3K27me3 (Supplementary Fig. S6a ). The extent of increase in H3K27me3 seems to be proportional to the degree of activation by Brg1 (Fig. 6a) . Hence, the increase in H3K27me3 is tightly correlated to the transcriptional status of a particular gene in Brg1-knockout ESCs. The gain of H3K27me3 mark after Brg1 deletion at representative BR1 genes ( Supplementary Fig. S6b ) occurs concurrently with transcriptional downregulation, and may be a cause rather than an indicator of silencing. Morever, H3K27me3 does not increase at these genes when LIF is withdrawn from wild-type ESCs ( Supplementary Fig.  S6c ), again indicating that the gain of H3K27me3 is not simply reflective of a loss of transcription. These observations indicate that in the absence of Brg1, H3K27me3 expands into STAT3-and Brg1-co-activated target genes, leading to the formation of repressive chromatin and transcriptional silencing. Representative browser shots of BR1 genes ( Fig. 6b and Supplementary Fig. S7 ) show that the increase in H3K27me3 is usually focused at or around the promoter (usually the TSS, shaded squares) but extends on average over a stretch of 2-4 kb. Although we have so far used STAT3 as a specific example of Brg1 and PRC2 antagonism, the increase in H3K27me3 at Brg1-activated genes is not limited to STAT3 target genes. Although Brg1 and Oct4/Sox2 act mostly antagonistically 11 , there are a small number of genes where these two factors co-bind and co-activate the nearest target gene. At the TSS of such genes, we also find an increase in H3K27me3 in Brg1-knockout ESCs when compared with wild-type ESCs (Fig. 6c) . Hence, PRC2-mediated silencing is not limited to STAT3-activated target genes, but extends to genes co-activated by Brg1 and Sox2 or Oct4. Brg1 generally prevents silencing of its actively transcribed target genes by preventing the encroachment of PRC2. As STAT3 and Brg1 co-activate a large number of genes, the relevance of this antagonism to the STAT3 pathway is more pronounced and significant, even if it is not exclusive to STAT3 targets. esBAF antagonizes the activity of the PRC2 complex at STAT3 target genes As the only enzymes known to catalyse the formation of H3K27me3 are Ezh1 and Ezh2 of PRC2, we formed a hypothesis that PRC2 is responsible for silencing of STAT3-dependent transcription in Brg1-knockout ESCs. Although PRC2 is not known to regulate LIF signalling, analysis of the microarray data of Suz12-knockout ESCs from ref. 34 revealed, surprisingly, that over 70% of Suz12-repressed genes are LIF activated. A two-dimensional (2D) gene density heat map visualization of the genes regulated by Suz12 and LIF revealed that LIF signalling is opposed by Suz12 (Fig. 7a, left) . In particular, Suz12 seems to repress direct STAT3 targets (Fig. 7a, bottom right) , which contrasts markedly with the role of Brg1. This strongly implies that Suz12 has previously unappreciated roles in modulating LIF signalling, perhaps by providing transient or basal antagonism of LIF-responsive genes, which may be critical for mediating exit from the pluripotent state. Consistent with these findings, we observed a significant increase in the levels of Suz12 at STAT3 target genes in Brg1-knockout ESCs (Fig. 7b) and increased binding of Jarid2 (jumonji, AT rich interactive domain 2; Fig. 7c ), which has been implicated in recruiting PRC2 to its targets [35] [36] [37] [38] . Again, this is not due to the loss of STAT3 binding, and does not reflect spontaneous differentiation by LIF withdrawal (Supplementary Fig. S8a ), indicating that the increased recruitment of PRC2 and the deposition of H3K27me3 precedes the loss of STAT3 binding. Hence, at Brg1/STAT3 co-bound and co-activated genes, Brg1 either antagonizes the activity of low levels of PRC2 complex already present at the site, or prevents an inappropriate increase in PRC2 recruitment that would otherwise lead to silencing of STAT3 target genes.
According to this model, removing PRC2 activity in Brg1-knockout ESCs should prevent silencing of Brg1 and STAT3 co-bound and co-activated genes and rescue their transcription. To this end, we carried out shRNA-mediated knockdown of the PRC2 component Suz12 using two distinct shRNA constructs (Supplementary Fig. S8b ). We chose Suz12 because of its role in maintaining the stability and activity of the PRC2 complex 39 and because of its apparent role in antagonizing LIF signalling. In Brg1-knockout ESCs, Suz12 depletion was sufficient to reduce H3K27me3 levels back to wild-type levels at affected Brg1-dependent STAT3 sites (Fig. 7d) , indicating that increased H3K27me3 levels at these STAT3-binding sites is PRC2 dependent. As our observations would predict, Suz12 depletion in Brg1-knockout ESCs resulted in partial to complete transcriptional rescue of Brg1-dependent STAT3 target genes (Fig. 7e) . Concurrently, the levels of STAT3 binding to its target sites, previously lost in the Brg1-knockout ESCs, were partially to fully restored (Fig. 7f) . These results indicate that Brg1 is required to prevent PRC2 and H3K27me3-mediated heterochromatinization of STAT3 target sites in ESCs so that these sites remain accessible to STAT3 and responsive to LIF signalling.
DISCUSSION
Our studies indicate that esBAF determines the pattern of STAT3 binding across the pluripotent genome. STAT3 signalling activates a very different group of genes in other cell types with distinct compositions of BAF complexes. We propose that the ESC genome is conditioned by the esBAF complex, which is present on chromatin before STAT3 binding, and can therefore contribute to determining which STAT3 target genes are activated in ESCs. In wild-type ESCs, Brg1 (and by inference esBAF complexes) mediates the accessibility of functional STAT3-binding sites, thereby facilitating robust STAT3 binding and STAT3-activated transcription in response to LIF (Fig. 8) . Without esBAF, STAT3 is still activated and localized to the nucleus but is unable to bind to most of its legitimate target sites in ESCs and is instead targeted to inappropriate sites. esBAF prevents the inappropriate silencing of STAT3 target genes by PcG complexes, ensuring that ESCs maintain LIF competency required for pluripotency. Unexpectedly, esBAF also synergizes with PcG at a subset of genes, including all four Hox clusters, ensuring their repression in ESCs.
The role of SWI/SNF-like complexes in signalling is not surprising, because the yeast SWI/SNF complex was discovered in screens for regulators of signal-dependent gene activation. However, in yeast, the transcription factor SWI5 seems to recruit SWI/SNF to its target genes 40 . In mammalian systems, STAT3 was shown in one case to be recruited to a target gene by an undefined Brg1-containing complex 41 ; however, other studies indicate the opposite, that is that STAT3 recruits Brg1 (ref. 42) . Our studies provide genome-wide evidence that STAT3 recruitment is dependent on the previous actions of Brg1. In our proteomic analysis of esBAF complexes we did not detect STAT3 peptides, indicating that it is unlikely that a stable interaction exists between esBAF and STAT3 in solution. However, esBAF occupancy also seems to be partially dependent on STAT3, indicating that the present models of unidirectional recruitment, either of STAT3 by Brg1 or of Brg1 by STAT3, are incomplete. Rather, we favour a model of interdependent recruitment. STAT3 binding is dependent on Brg1 preassembly on target chromatin. In turn, steady-state occupancy of esBAF is reinforced by bound STAT3. The nature of the antagonistic roles between PcG and Brg1 has been a matter of much debate [21] [22] [23] . Our studies demonstrate that genome wide, Brg1 excludes PcG function because Brg1 deletion leads to the invasion of PcG at the sites we have tested and most Brg1-activated genes show an increase in H3K27me3 and transcriptional silencing. Thus, we favour a mechanism of opposition in which Brg1 prevents PcG binding to a large group of genes including LIF/esBAF targets (Fig. 8) . This is clearly not due to a loss of transcription, because removing LIF does not lead to PcG binding and H3K27me3 deposition. In human rabdhoid tumours caused by the deletion of SNF5, re-expression of SNF5 leads to eviction of PcG and reduced H3K27me3 at the Ink4a (also known as Cdkn2a) locus 22 , which is consistent with the genome-wide antagonism we report.
In contrast to textbook descriptions of the antagonism between Brm and PcG, we find that esBAF synergizes with PRC2 at all four Hox loci (Fig. 8) , which must be effectively silenced in ESCs to prevent premature differentiation. Previous studies have not uncovered the presence of synergism between BAF and PcG complexes because only single genes were examined 43 , and because synergism was not expected in light of early studies in Drosophila 44 . This unexpected finding may be restricted to ESCs and may arise from the fact that ESCs contain a specialized SWI/SNF-like BAF complex (esBAF) not found in other cell types.
Hence, Brg1 seems to function in synergy with PcG to repress differentiation genes in ESCs, while preventing PcG-mediated repression of pluripotency-related genes activated by ESC transcription factors such as STAT3, Oct4 and Sox2. These findings imply that esBAF regulates the activity of PcG across the genome in both positive and negative modes. Clearly an important future goal will be to understand the biochemical basis of the ability of Brg1 to direct PcG function. This more complex view of the function of Brg1 is consistent with the observation that mutations in Brg1, Brm or other components of mammalian BAF complexes have not shown homeotic-like defects in mice. Thus, during the course of evolution, the interplay between Brm-based chromatin remodelling complexes and PcG has expanded beyond mere antagonism. Nevertheless, the two complexes seem to use both their synergistic and antagonistic functions to facilitate and maintain the pluripotent state. ;actin-CreER male mice. Embyros were cultured on mouse embryonic fibroblasts (MEFs) in ES media (with 15% knockout serum replacement and 3,000 U ml −1 ESGRO LIF). After 5-6 days of culture, inner cell mass outgrowths from the embryos were dissociated by trypsin digestion and passaged onto MEF feeders. Single colonies were picked from these bulk cultures, expanded and genotyped to obtain Brg 1 lox/lox ;actin-CreER ESC clones or Brg1 cond ESCs. We carried out all of our experiments with line 6-14, which was karyotypically normal. Throughout the study, unless otherwise indicated, we treated the cultures grown on MEFs with 1 µM 4-OHT ( Sigma; dissolved in ethanol) for 24 h, then passaged them onto gelatinized plates for 48 more hours of 4-OHT treatment to induce Brg1 deletion. As a control, 6-14 Brg1 cond cells were treated with ethanol, which does not induce Cre expression. Brg1 protein levels are completely abolished only at 48 h. Hence, Brg1-knockout ESCs experience about 24 h in the complete absence of Brg1.
METHODS
Methods
DNaseI accessibility assay DNaseI accessibility assays were carried out according to ref. 31 , with the following modifications. An equal amount of Drosophila genomic DNA (from S2 cells) was spiked into each reaction as an internal loading control to minimize variations arising from the phenol-chloroform extraction procedure. The undigested input sample was then briefly sonicated to solubilize it to enable more accurate pipetting. qPCR was carried out with primers spanning STAT3-binding sites or control region (see Supplementary Table S2 ). An S2-specific primer set was used as an internal control. Target sites were chosen from genes in Supplementary  Table S1 and are the same gene set used in ChIP assays throughout the manuscript. DnaseI accessibility for each sample was then calculated as:
Data sets used in this study. ChIP-seq data sets from mESCs were obtained from ChIP. ChIP experiments were carried out with EZ-ChIP (Millipore) according to the manufacturer's instructions with certain modifications. ESCs were fixed on-plate with 1% formaldehyde in PBS for 12 min. Cells (10 million) were resuspended in 1 ml ChIP buffer (0.1% SDS, 1 mM EDTA, 20 mM Tris-HCl at pH 8.1, 150 mM NaCl and 0.1% Triton X-100) and sonicated for 9-10 cycles, 30 seconds per cycle with a 60 s rest between each cycle, at Power 6 on the Misonix Sonicator 3000. The supernatant was then diluted to a protein concentration of 1.7 mg ml −1 and 350-500 µg of protein was used for each immunoprecipitation reaction. See Supplementary Table S2 for primers used in qPCR of ChIP DNA.
Antibodies used in this study. A list of antibodies used in this study and their dilutions for different applications is available in the Supplementary Information.
ChIP-seq and peak calling. Sequenced 36-bp reads from STAT3 ChIP-seq experiments were mapped to the mouse genome (mm8 assembly) using the Solexa Analysis Pipeline. Only those reads that mapped to unique genomic locations with at most two mismatches were retained for further analysis. This resulted in 13.4 and 12.6 million reads for STAT3 ChIP and 53.9 and 51.2 million reads for H3K27me3 in wild-type and Brg1-knockout cells, respectively. For control, input DNA libraries were sequenced in both wild-type and Brg1-knockout cells, yielding a net 14.3 and 14.5 million reads, respectively. STAT3 and the input DNA reads were processed further using the SISSRs tool 27 to identify STAT3-binding sites in wild-type and Brg1-knockout cells. SISSRs was run with -a and other default options with the P value threshold set to 0.01. A total of 2,729 and 545 STAT3-binding sites were detected in wild-type and Brg1-knockout cells. Of the 2,729 STAT3 sites in wild-type cells, 442 were also detected to bind STAT3 in Brg1-knockout cells (referred to as Brg1-dependent STAT3 sites). The remaining 2,287 STAT3 sites in wild-type cells, which were lost on Brg1 knockout, were considered as Brg1-independent STAT3 sites. ChIP-seq reads for Brg1 and input DNA in E14 wild-type ESCs, obtained from our previous study 11 , were reanalysed using a more stringent approach (as described previously 48 ) to define Brg1-binding regions (peaks). In brief, the 25-bp reads were extended to 300 bp in the 3 direction to account for the average 300-bp length ChIP DNA fragments size-selected for sequencing. The read coverage at individual nucleotides at 20-bp resolution was determined by counting the number of extended reads that map to 20-bp intervals. Brg1-binding regions were identified by comparing the observed frequency of coverage depths with those expected from a random distribution of the same number of reads. The probability of observing a Brg1 peak with a coverage depth of at least R by chance is given by a sum of Poisson probabilities as 1 − R−1 n=0 (e −λ λ n /n!), where λ is the average genome-wide coverage of extended reads. The mappable genome length, which was estimated to be about 80% of the genome, and the smallest coverage depth T at which the ratio of the expected number of sites with at least that coverage to the observed number is at most 0.01 was determined (false discovery rate, FDR ≤ 0.01). Candidate Brg1 peaks were identified by selecting sites at which the read coverage exceeded T , and the peak boundaries were extended to the nearest flanking position at which the read coverage fell below two reads. Overlapping peaks were merged into a single peak. Consecutive peaks separated by two times the average ChIP DNA fragment size were merged into a single peak as well, to account for regions with a lack of coverage depth. Peaks mapping to satellite repeats, ribosomal RNA repeats and those that have also been reported as peaks in the control input DNA sample were discarded. The remaining 10,829 peaks were considered to be the high-confidence Brg1-binding regions. Although the number of Brg1-binding regions identified in this manner is similar in number to Brg1 islands we had reported previously 11 , the median width of the Brg1-bound regions identified as described above is 700 bp, compared with 6.5 kb that we had reported previously. The main reason for this difference is that the strategy outlined above for identifying binding regions helped reduce the number of false positives (compared with our previous approach) and at the same time increased the resolution of the identified binding regions by breaking up previously defined large Brg1-binding islands. All of our results reported in this study as well as those in our previous study 11 remain the same regardless of whether we use Brg1-binding regions defined in this study or Brg1 islands defined in our previous study (data not shown).
Target gene assignment. Throughout the manuscript, direct target genes of a particular factor (for example, STAT3 or Brg1) are defined as genes that have one more detected factor peak(s) by ChIP-seq analysis within 5 kb upstream of the transcription start site (TSS) to the end of the gene (transcription end site).
Direct STAT3 and Brg1 target genes.
We applied several filters to obtain a set of direct target genes and functional target sites of both Brg1 and STAT3, because LIF activates both STAT3 as well as the MAPK and PI(3)K/AKT pathways (reviewed in ref. 49); many changes we observed may be secondary targets, and many STAT3 and Brg1 sites detected in our ChIP-seq studies may be non-functional sites that do not control expression of any target gene. First, genes that were co-bound or co-activated by Brg1 and STAT3 were identified. A gene was considered a direct target of Brg1/STAT3 only if a Brg1/STAT3-binding site is located within 5 kb upstream of its transcription start site (TSS) or within its annotated gene body. Of the Brg1 and STAT3 sites assigned to direct target genes, a binding site is considered functional only if the transcription of the assigned target gene is altered by at least 1.5-fold in the absence of Brg1 or LIF. In this way, we defined direct target genes as well as functional binding sites of Brg1 and STAT3 to use throughout the study. We also examined several genes with potential roles in pluripotency from BR1 of the gene density heat map derived using STAT3-binding sites defined previously 29 .
Microarray data analysis. Purified RNA was processed and hybridized onto Affymetrix Mouse MOE4.0 3 expression arrays according to the manufacturer's instructions (Affymetrix).
Generation of 2D matrices and gene density heat map. The 17,030 UCSC
known genes with expression data in ESCs, obtained from a published microarray data of wild-type E14 ESCs 24 , were grouped into 10 bins on the basis of expression. To study the role of Brg1 in LIF/STAT3 signalling in ESCs, we first computed the fold change for 17,030 known genes in Brg1-knockout compared with the wild-type ESCs. To avoid including genes with artificial fold changes (nil to negligible or vice versa), genes with the lowest 15th percentile of expression were removed in both the wild-type and the knockout/knockdown samples. The resulting genes from each data set were then grouped into 10 bins on the basis of the fold change. Using the same strategy, we also grouped genes into 10 bins on the basis of the fold change in ESCs with and without LIF, and compared embryoid body cells with ESCs 50 . The relationship between two data sets (10-bin sets) was assessed by carrying out pairwise comparisons of bins from the two data sets, and counting the number of genes in common between every pair of bins. The resultant matrix containing the number of common genes was plotted as a gene density heat map to infer the interplay between the functional roles between Brg1 and LIF/STAT3. STAT3 motif analysis. MEME was used to identify sequence motifs within STAT3-binding sites.
Data deposition. All ChIP-seq and microarray data have been deposited in GEO Onmibus (NCBI) with an accession number of GSE27708. experiments. B) Protein levels of PRC2 components Suz12 and Ezh2 following either control or Suz12 shRNA-mediated knockdown. Two distinct Suz12 knockdown constructs are utilized, both separately and together. Knockdown constructs were delivered via lentiviral transduction and protein levels were measured 4 days post-infection and puromycin selection. Figure 1A . Western blot for levels of Brg and pluripotency markers Oct4, Soz2 and Nanog, with GapdH as the loading control. Western blots are performed on the LiCOR Odessey platform with secondary antibodies that emit in the far-red spectrum. Hence, the same blot is scanned twice in different channels (700 and 800), with the 700 channel detecting mouse primary antibodies and the 800 channel depicting anti rabbit primary antibodies. This is consistent throughout the rest of this supplementary document where Western blots are depicted, unless otherwise stated. (B) Uncropped gels shown in Figure 1D . Western blot depicting STAT3 Protein levels in WT versus KO ESCs (72 hours 4OHT STAT3P=Phosphotyrosine705 STAT3; LIFR=LIF receptor) in the presence of LIF (+) or after 18 hours of LIF starvation (-). (C) Uncropped gels shown in Figure 1E . Timecourse of STAT3 activation in BrgWT and KO ESCs. Cells were starved for 18 hours from LIF (-), followed by LIF restimuation for the indicated durations. 
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